BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 16912011)

  • 21. Cancer-induced retinal hypersensitivity.
    Thirkill CE
    Br J Biomed Sci; 1996 Sep; 53(3):227-34. PubMed ID: 8914351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoimmune retinopathy and antiretinal antibodies: a review.
    Grewal DS; Fishman GA; Jampol LM
    Retina; 2014 May; 34(5):827-45. PubMed ID: 24646664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer-associated retinopathy in patients with breast carcinoma.
    Misiuk-Hojło M; Ejma M; Gorczyca WA; Szymaniec S; Witkowska D; Fortuna W; Miedzybrodzki R; Rogozińska-Szczepka J; Bartnik W
    Arch Immunol Ther Exp (Warsz); 2007; 55(4):261-5. PubMed ID: 17659379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Latest updates on antiretinal autoantibodies associated with vision loss and breast cancer.
    Adamus G
    Invest Ophthalmol Vis Sci; 2015 Mar; 56(3):1680-8. PubMed ID: 25754855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paraneoplastic neurological syndromes.
    Honnorat J; Antoine JC
    Orphanet J Rare Dis; 2007 May; 2():22. PubMed ID: 17480225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term survival of a patient with small cell lung cancer associated with cancer-associated retinopathy.
    Kobayashi M; Ikezoe T; Uemura Y; Ueno H; Taguchi H
    Lung Cancer; 2007 Sep; 57(3):399-403. PubMed ID: 17397962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoimmune retinopathy.
    Braithwaite T; Vugler A; Tufail A
    Ophthalmologica; 2012; 228(3):131-42. PubMed ID: 22846442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer-associated retinopathy in a patient with advanced epithelial ovarian carcinoma.
    Harmon JP; Purvin VA; Guy J; Aptsiauri N; Sutton GP
    Gynecol Oncol; 1999 Jun; 73(3):430-2. PubMed ID: 10366473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paraneoplastic autoimmune multiorgan syndrome: review of the literature and support for a cytotoxic role in pathogenesis.
    Billet SE; Grando SA; Pittelkow MR
    Autoimmunity; 2006 Nov; 39(7):617-30. PubMed ID: 17101506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of cytotoxic T lymphocyte antigen 4 (CTLA4) signaling and locally applied steroid on retinal dysfunction by recoverin, cancer-associated retinopathy antigen.
    Maeda A; Maeda T; Liang Y; Yenerel M; Saperstein DA
    Mol Vis; 2006 Aug; 12():885-91. PubMed ID: 16917481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of autoimmune-related retinopathy and optic neuropathy syndrome treated by autologous nonmyeloablative hematopoietic stem cell transplantation.
    Oyama Y; Burt RK; Thirkill C; Hanna E; Merrill K; Keltner J
    J Neuroophthalmol; 2009 Mar; 29(1):43-9. PubMed ID: 19458576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Paraneoplastic retinopathy simulating cone dystrophy with achromatopsia].
    Cogan DG; Kuwabara T; Currie J; Kattah J
    Klin Monbl Augenheilkd; 1990 Aug; 197(2):156-8. PubMed ID: 2243476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer-associated retinopathy vs recoverin-associated retinopathy.
    Keltner JL; Thirkill CE
    Am J Ophthalmol; 1998 Aug; 126(2):296-302. PubMed ID: 9727525
    [No Abstract]   [Full Text] [Related]  

  • 34. Non-Paraneoplastic Autoimmune Retinopathy: The First Case Report in Korea.
    Choi EY; Kim M; Adamus G; Koh HJ; Lee SC
    Yonsei Med J; 2016 Mar; 57(2):527-31. PubMed ID: 26847311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bilateral diffuse uveal melanocytic proliferation in a patient with cancer-associated retinopathy.
    Saito W; Kase S; Yoshida K; Ohguro H; Yokoi M; Iwaki H; Ohno S
    Am J Ophthalmol; 2005 Nov; 140(5):942-5. PubMed ID: 16310487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Slowly progressive non-neoplastic autoimmune-like retinopathy.
    Ohta K; Kikuchi T; Yoshida N
    Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):155-8. PubMed ID: 20625760
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immunology in the clinical practice. XVI. Paraneoplastic syndromes of the nervous system: pathogenesis and diagnosis].
    Smitt PA; de Leeuw B; Vecht CJ
    Ned Tijdschr Geneeskd; 1998 Jul; 142(29):1652-8. PubMed ID: 9763856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paraneoplastic syndromes in neuro-ophthalmology.
    Alabduljalil T; Behbehani R
    Curr Opin Ophthalmol; 2007 Nov; 18(6):463-9. PubMed ID: 18162997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy.
    Adamus G
    Autoimmun Rev; 2009 Mar; 8(5):410-4. PubMed ID: 19168157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute progressive paravascular placoid neuroretinopathy with negative-type electroretinography in paraneoplastic retinopathy.
    Chen FK; Chew AL; Zhang D; Chen SC; Chelva E; Chandrasekera E; Koay EMH; Forrester J; McLenachan S
    Doc Ophthalmol; 2017 Jun; 134(3):227-235. PubMed ID: 28382556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.